CW Ventures
8
24M
5
0.38
4
- Stages of investment
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.
The top activity for fund was in 2001. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2011. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this CW Ventures performs on 21 percentage points more the average number of lead investments.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the CW Ventures, startups are often financed by ARCH Venture Partners, Venrock, Tredegar Investments. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Venrock, HBM Healthcare Investments AG. In the next rounds fund is usually obtained by ARCH Venture Partners, Venrock, MPM Capital.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Biotechnology, Clinical Trials. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Fast Track, Amphora Discovery, Surface Logix.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 0
- Exits
- 4
- Follow on index
- 0.38
- Investments by industry
- Health Care (6)
- Biotechnology (5)
- Biopharma (3)
- Business/Productivity Software (2)
- Other Software (2) Show 13 more
- Investments by region
-
- United States (8)
- Peak activity year
- 2002
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 194M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 2.87
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Surface Logix | 27 Nov 2002 | Biotechnology, Health Care, Biopharma | Late Stage Venture | 25M | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.